Retinoic acid-related orphan receptor γ (RORγ): a novel participant in the diurnal regulation of hepatic gluconeogenesis and insulin sensitivity

• Published in: PLoS genetics 2014-05, Vol.10 (5), p.e1004331
• Main Authors: Takeda, Yukimasa, Kang, Hong Soon, Freudenberg, Johannes, DeGraff, Laura M, Jothi, Raja, Jetten, Anton M
• Format: Article
• Language: English
• Subjects: Animals; Biology and life sciences; Circadian Rhythm - genetics; Circadian rhythms; Diabetes Mellitus, Type 2 - genetics; Diabetes Mellitus, Type 2 - metabolism; Diabetes Mellitus, Type 2 - pathology; Gene expression; Gene Expression Regulation - drug effects; Genetic aspects; Genetic research; Gluconeogenesis - drug effects; Gluconeogenesis - genetics; Glucose - metabolism; Health aspects; Humans; Insulin - genetics; Insulin - metabolism; Insulin Resistance; Liver - metabolism; Liver - pathology; Medicine and Health Sciences; Mice; Nuclear Receptor Subfamily 1, Group F, Member 3 - biosynthesis; Nuclear Receptor Subfamily 1, Group F, Member 3 - deficiency; Nuclear Receptor Subfamily 1, Group F, Member 3 - genetics; Tretinoin; Tretinoin - pharmacology
• ISSN: 1553-7404; 1553-7390; 1553-7404
• DOI: 10.1371/journal.pgen.1004331

The hepatic circadian clock plays a key role in the daily regulation of glucose metabolism, but the precise molecular mechanisms that coordinate these two biological processes are not fully understood. In this study, we identify a novel connection between the regulation of RORγ by the clock machinery and the diurnal regulation of glucose metabolic networks. We demonstrate that particularly at daytime, mice deficient in RORγ exhibit improved insulin sensitivity and glucose tolerance due to reduced hepatic gluconeogenesis. This is associated with a reduced peak expression of several glucose metabolic genes critical in the control of gluconeogenesis and glycolysis. Genome-wide cistromic profiling, promoter and mutation analysis support the concept that RORγ regulates the transcription of several glucose metabolic genes directly by binding ROREs in their promoter regulatory region. Similar observations were made in liver-specific RORγ-deficient mice suggesting that the changes in glucose homeostasis were directly related to the loss of hepatic RORγ expression. Altogether, our study shows that RORγ regulates several glucose metabolic genes downstream of the hepatic clock and identifies a novel metabolic function for RORγ in the diurnal regulation of hepatic gluconeogenesis and insulin sensitivity. The inhibition of the activation of several metabolic gene promoters by an RORγ antagonist suggests that antagonists may provide a novel strategy in the management of metabolic diseases, including type 2 diabetes.